Cleveland BioLabs Stock Price and Value Analysis

Should you buy Cleveland BioLabs stock? (NasdaqCM:CBLI). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This company has wild ups and downs.
  • This company is not making money.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the CBLI Numbers

CBLI Price
(Cleveland BioLabs stock price per share)
[?] PE Ratio versus Sector 1407% higher than other Healthcare stocks
[?] PE Ratio versus Industry 428% higher than other Biotechnology stocks
[?] Cash Yield -34.49%
[?] Free Cash Flow Jitter 42%

Is Cleveland BioLabs Stock on Sale?

Based on our analysis, we believe that you should not buy Cleveland BioLabs right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy CBLI Stock?

Does Cleveland BioLabs have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.